AeroVironment
AVAV
$184.97
-5.15%
AeroVironment, Inc. is a defense technology provider specializing in unmanned aircraft systems (UAS), tactical missile systems, and high-altitude pseudo-satellites, primarily serving the U.S. Department of Defense and allied international governments. The company is a recognized leader and niche player in the unmanned systems and counter-UAS segments, delivering integrated capabilities across air, land, sea, space, and cyber domains. The current investor narrative is intensely focused on the volatile interplay between strong secular tailwinds from rising global defense budgets and significant company-specific execution risks, as recent headlines highlight a major contract termination, a substantial goodwill impairment charge, and an earnings miss that have cratered the stock, despite a record backlog and bullish long-term outlook for its counter-drone technologies.…
AVAV
AeroVironment
$184.97
Related headlines
AVAV 12-Month Price Forecast
Wall Street consensus
Most Wall Street analysts maintain a constructive view on AeroVironment's 12-month outlook, with a consensus price target around $240.46 and implied upside of +30.0% versus the current price.
Average Target
$240.46
6 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
6
covering this stock
Price Range
$148 - $240
Analyst target range
Analyst coverage consists of 6 firms, and the recent institutional ratings show a pattern of reiterated bullish stances following the Q3 earnings report in March 2026, with firms like BTIG, Canaccord, Jefferies, and Needham maintaining Buy ratings, and Raymond James upgrading from Underperform to Market Perform. The consensus recommendation leans bullish, but the average target price is not provided in the data, preventing a calculation of implied upside or downside from the current $196.28. The target range is also not specified, but the recent cluster of 'Buy' and 'Outperform' ratings in the face of terrible quarterly results suggests analysts are looking through near-term impairments to the record backlog and counter-drone leadership, viewing the sell-off as overdone. The wide dispersion in analyst actions—from an upgrade to Market Perform to steadfast Buys—signals high uncertainty and debate about the timing and magnitude of a potential recovery, with the low target likely pricing in further contract losses and the high target assuming a full rebound on defense budget tailwinds.
Bulls vs Bears: AVAV Investment Factors
The evidence currently favors the bear case due to the severity and immediacy of the fundamental deterioration revealed in Q3, including catastrophic margin collapse, a major contract loss, and sustained cash burn. The bull case relies heavily on forward-looking analyst faith in defense budget tailwinds and a record backlog, but these are overshadowed by present execution failures. The single most important tension in the investment debate is the credibility of management's turnaround narrative versus the hard data of operational collapse. If the company can demonstrate contract stability and margin recovery in the next quarter, the bull thesis gains traction; if not, the stock risks re-testing its 52-week low as a value trap.
Bullish
- Record Backlog Amid Defense Tailwinds: Analysts highlight a record backlog and leadership in counter-drone technology as a key bullish factor, viewing the company as the 'only game in town' in a critical defense niche. This is supported by news of a proposed $200 billion increase in defense spending, which directly benefits AeroVironment's core unmanned systems and AI targeting products.
- Analyst Conviction Despite Poor Q3: Multiple firms (BTIG, Canaccord, Jefferies, Needham) reiterated Buy ratings after the disastrous Q3 results, signaling a belief that the sell-off is overdone relative to long-term prospects. This institutional support provides a valuation floor and suggests the near-term impairments are viewed as non-recurring.
- Valuation at Historical Lows: The stock's PS ratio of 5.17x is near the bottom of its historical range, having collapsed from levels above 30x in late 2025. This dramatic compression to near-historical lows suggests the market has priced in severe deterioration, creating a potential deep-value opportunity if operations stabilize.
- Strong Balance Sheet Provides Buffer: The company maintains a robust current ratio of 3.52 and a very low debt-to-equity ratio of 0.07. This financial flexibility provides a crucial buffer to navigate near-term operational challenges and invest in growth without immediate liquidity concerns.
Bearish
- Catastrophic Q3 Earnings Miss: Q3 FY2026 results were disastrous, with a net loss of $156.6M (including a goodwill impairment), revenue growth of just 1.43% YoY, and a severe gross margin compression to 17.1% from 39.4%. This indicates fundamental operational breakdown, not just a timing issue.
- Major Contract Termination & Uncertainty: The termination of a critical $1.7B U.S. Space Force contract and reports that a $1.4B contract may be reopened for bidding create massive revenue uncertainty. This directly undermines the 'record backlog' narrative and exposes significant customer concentration and execution risk.
- Severe Cash Burn & Negative Profitability: The company generated negative free cash flow of $17.7M in Q3 and negative TTM FCF of $195.3M, with a negative ROA of -1.26%. This cash burn, coupled with a P/CF ratio of -3221, raises serious questions about the sustainability of its business model without external financing.
- Technical Breakdown & High Volatility: The stock is in a severe downtrend, down 48.1% over six months and trading near 40% of its 52-week range ($147.17-$417.86). With a beta of 1.38, it is 38% more volatile than the market, amplifying downside risk and making it a 'falling knife' for momentum investors.
AVAV Technical Analysis
The prevailing price trend is a severe and sustained downtrend, with the stock down 48.1% over the past six months and 36.2% over the last three months, despite a positive 31.8% one-year change. The current price of $196.28 sits at approximately 40% of its 52-week range ($147.17 to $417.86), indicating the stock is trading much closer to its annual lows than its highs, which suggests either a deep value opportunity or a fundamental 'falling knife' scenario given the recent precipitous decline. Recent momentum is decisively negative and diverging sharply from the longer-term uptrend, with the stock down 1.4% over the past month while the SPY gained 8.7%, resulting in a severe relative strength reading of -10.1 over that period; this divergence signals a significant breakdown in the prior bullish thesis, likely driven by the Q3 earnings miss and contract news. Key technical support is at the 52-week low of $147.17, while resistance lies at the recent breakdown levels near $250 and the 52-week high of $417.86; a sustained break below $147 would signal a complete loss of confidence, while reclaiming the $250-$280 zone is necessary for any recovery narrative. With a beta of 1.38, the stock is 38% more volatile than the broader market, which amplifies both downside risk and potential upside during sector rallies, demanding careful risk management.
Beta
1.38
1.38x market volatility
Max Drawdown
-56.8%
Largest decline past year
52-Week Range
$154-$418
Price range past year
Annual Return
+19.2%
Cumulative gain past year
| Period | AVAV Return | S&P 500 |
|---|---|---|
| 1m | +0.8% | +10.0% |
| 3m | -33.6% | +4.1% |
| 6m | -50.0% | +5.7% |
| 1y | +19.2% | +29.0% |
| ytd | -27.8% | +5.7% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
AVAV Fundamental Analysis
Revenue growth has decelerated sharply and profitability has collapsed in the most recent quarter. For Q3 FY2026 (ended Jan 31, 2026), revenue was $408.0 million, representing a modest 1.43% year-over-year growth, but this follows a significant sequential decline from Q2's $472.5 million. The company is deeply unprofitable on a net income basis, posting a Q3 net loss of $156.6 million, which includes a substantial non-cash goodwill impairment charge. Gross margin compressed severely to 17.1% in Q3, down from 39.4% in the prior-year period and 17.4% in Q2, indicating intense pressure on product mix or pricing. The balance sheet and cash flow position reveal significant strain; while the company maintains a strong current ratio of 3.52 and a low debt-to-equity ratio of 0.07, it generated negative free cash flow of $17.7 million in Q3 and negative TTM free cash flow of $195.3 million. The negative ROA of -1.26% and modest ROE of 4.92% reflect inefficient asset utilization and poor returns to shareholders in the recent period, raising questions about the sustainability of its growth investments without external financing.
Quarterly Revenue
$408045000.0B
2026-01
Revenue YoY Growth
+1.43%
YoY Comparison
Gross Margin
+0.17%
Latest Quarter
Free Cash Flow
$-195302000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is AVAV Overvalued?
Given the negative net income in the most recent quarter, we lead with the Price-to-Sales (PS) ratio for valuation. The stock trades at a trailing PS ratio of 5.17x and a forward PS ratio implied by analyst revenue estimates is not provided, but the high P/CF ratio of -3221 and negative PEG of -3.38 highlight the cash flow and growth challenges embedded in the current price. Compared to industry averages, a PS ratio of 5.17x is difficult to contextualize without a specific sector benchmark, but the elevated EV/Sales of 6.38x suggests the market is still assigning a premium enterprise value relative to sales, likely on future defense budget expectations. Historically, the stock's own valuation has compressed dramatically; its current PS of 5.17x is near the bottom of its recent historical range, having fallen from levels above 30x in late 2025. This plunge to near-historical lows suggests the market is pricing in significant fundamental deterioration or a permanent impairment of growth prospects, rather than a temporary setback, creating a potential value trap if the operational issues persist.
PE
97.3x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range -820x~33224x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
40.9x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks are acute and center on profitability collapse and cash burn. The Q3 gross margin of 17.1% represents a catastrophic drop from 39.4% a year ago, indicating severe product mix or pricing issues that may not be temporary. The negative TTM free cash flow of $195.3M and a P/CF ratio of -3221 signal the business is consuming cash at an unsustainable rate to fund operations. Revenue concentration risk is starkly highlighted by the termination of a single $1.7B Space Force contract, which can materially impact future top-line growth and calls into question the stability of the 'record backlog.'
Market & Competitive Risks are elevated by valuation compression and sector volatility. Despite the recent plunge, the EV/Sales of 6.38x suggests the market still assigns a premium enterprise value, leaving room for further multiple contraction if growth fails to materialize. The successful $320M IPO of drone maker AEVEX highlights intense competition and investor appetite for newer entrants in the unmanned systems space, potentially diverting capital and contracts. With a beta of 1.38, AVAV is highly sensitive to broader market swings and sector rotations out of defense stocks if geopolitical tensions ease.
Worst-Case Scenario involves a continuation of contract losses, failed margin recovery, and a loss of analyst confidence. The specific chain would be: another major program cancellation, Q4 gross margins remaining below 20%, and consequent analyst downgrades from their current bullish stance. This could trigger a re-test and break of the 52-week low of $147.17. From the current price of $196.28, this represents a realistic downside of approximately -25%. A more severe scenario, aligning with the stock's maximum drawdown of -56.82% over the provided period, could see the stock fall toward the $120-$130 range if the operational crisis deepens.